The intestine harbours a complex array of microorganisms collectively known as the gut
microbiota. The past two decades have witnessed increasing interest in studying the gut …

Following cancer, cells in a particular tissue can no longer respond to the factors involved in
controlling cell survival, differentiation, proliferation, and death. In recent years, it has been …

Human gut microbiota play an essential role in both healthy and diseased states of humans.
In the past decade, the interactions between microorganisms and tumors have attracted …

The human microbiome plays an integral role in physiology, with most microbes considered
benign or beneficial. However, some microbes are known to be detrimental to human health …

Inflammatory bowel disease (IBD) involves chronic inflammation, loss of epithelial integrity,
and gastrointestinal microbiota dysbiosis, resulting in the development of a colon cancer …

Pre-clinical and clinical data produce mounting evidence that the microbiota is strongly
associated with colorectal carcinogenesis. Dysbiosis may change the course of …

Gut dysbiosis contributes to the development of a dysfunctional gut barrier, facilitating the
translocation of bacteria and inflammagens, and is implicated in colorectal cancer (CRC) …

The association of diabetes with inflammatory bowel disease (IBD) remains unclear. The risk
of diabetes in patients with IBD compared with non-IBD controls was investigated. Using the …

Inflammation is a natural defense process of the innate immune system, associated with the
release of proinflammatory cytokines such as interleukin-1β, interleukin-6, interleukin-12 …

Objective To assess whether the use of dipeptidyl peptidase-4 inhibitors is associated with
the incidence of inflammatory bowel disease in patients with type 2 diabetes. Design …